恶化性心力衰竭中的铁缺乏与估算蛋白质摄入减少、液体潴留、炎症及抗血小板药物使用相关
本研究基于BIOSTAT-CHF队列2357例恶化性心力衰竭患者,以转铁蛋白饱和度<20%定义铁缺乏,发现其患病率为61.6%,女性更高。独立决定因素包括女性、较低估算蛋白质摄入、较高心率、外周水肿和端坐呼吸、慢性肾脏病、较低血红蛋白、较高C反应蛋白、较低血清白蛋白及P2Y12抑制剂使用。铁缺乏与更差结局独立相关(HR 1.25,95%CI 1.06-1.46;P=0.007)。
要点
- 恶化性心衰患者铁缺乏患病率高达61.6%,女性更常见。
- 铁缺乏独立决定因素包括营养不良、液体潴留、炎症、肾功能不全及抗血小板药物使用。
- 铁缺乏与全因死亡和心衰再住院复合终点独立相关(HR 1.25)。
核心结论
- 恶化性心衰中铁缺乏病因复杂、多因素,涉及铁摄入减少、储存受损和丢失增加。
- 铁缺乏与更差临床结局独立相关。
研究设计与样本
- BIOSTAT-CHF国际队列研究,纳入2357例恶化性心衰患者。
- 铁缺乏定义为转铁蛋白饱和度<20%,采用单变量和多变量logistic回归分析决定因素。
- 检测92种心血管标志物(Olink Cardiovascular III)建立生物标志物谱。
- 主要终点为全因死亡和首次心衰再住院的复合终点。
主要发现
- 患者平均年龄69±12.0岁,女性占26.1%,NT-proBNP中位数4305(2360-8329)ng/L。
- 铁缺乏患病率为61.6%(1453例),女性71.1% vs 男性58.3%(P<0.001)。
- 独立决定因素包括女性、较低估算蛋白质摄入、较高心率、外周水肿和端坐呼吸、慢性肾脏病、较低血红蛋白、较高C反应蛋白、较低血清白蛋白及P2Y12抑制剂使用(均P<0.05)。
- 铁缺乏的生物标志物谱主要为促炎标志物,包括PON3和抗酒石酸酸性磷酸酶5。
- 多变量Cox回归显示铁缺乏与更差结局独立相关(HR 1.25,95%CI 1.06-1.46;P=0.007)。
临床怎么用
- 对恶化性心衰患者应评估铁缺乏,尤其女性、营养不良、液体潴留、炎症、肾功能不全及使用P2Y12抑制剂者。
- 铁缺乏与不良预后相关,提示需关注并可能纠正铁缺乏。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Iron deficiency (ID) is common in heart failure (HF) patients and negatively impacts symptoms and prognosis. The aetiology of ID in HF is largely unknown. We studied determinants and the biomarker profile of ID in a large international HF cohort. METHODS AND RESULTS: We studied 2357 worsening HF patients from the BIOSTAT-CHF cohort. ID was defined as transferrin saturation <20%. Univariable and multivariable logistic regression models were constructed to identify determinants for ID. We measured 92 cardiovascular markers (Olink Cardiovascular III) to establish a biomarker profile of ID. The primary endpoint was the composite of all-cause mortality and first HF rehospitalization. Mean age (±standard deviation) of all patients was 69 ± 12.0 years, 26.1% were female and median N-terminal pro B-type natriuretic peptide levels (+interquartile range) were 4305 (2360-8329) ng/L. Iron deficiency was present in 1453 patients (61.6%), with highest prevalence in females (71.1% vs. 58.3%; P < 0.001). Independent determinants of ID were female sex, lower estimated protein intake, higher heart rate, presence of peripheral oedema and orthopnoea, chronic kidney disease, lower haemoglobin, higher C-reactive protein levels, lower serum albumin levels, and P2Y12 inhibitor use (all P < 0.05). None of these determinants were sex-specific. The biomarker profile of ID largely consisted of pro-inflammatory markers, including paraoxonase 3 (PON3) and tartrate-resistant acid phosphatase type 5. In multivariable Cox proportional hazard regression analyses, ID was associated to worse outcome, independently of predictors of ID (hazard ratio 1.25, 95% confidence interval 1.06-1.46; P = 0.007). CONCLUSION: Our data suggest that the aetiology of ID in worsening HF is complex, multifactorial and seems to consist of a combination of reduced iron uptake (malnutrition, fluid overload), impaired iron storage (inflammation, chronic kidney disease), and iron loss (antiplatelets).
引用
- van der Wal HH, Grote Beverborg N, Dickstein K, et al. Iron deficiency in worsening heart failure is associated with reduced estimated protein intake, fluid retention, inflammation, and antiplatelet use. Eur Heart J. 2019. PMID: 31556953. doi:10.1093/eurheartj/ehz680
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。